a better analogy than the generic drug analogy may be to a commons-based licensing approach that has been proposed in the biotech area (a/k/a "open source biotech").
Prof. Arti Rai at Duke Law has written about this.
http://www.law.duke.edu/fac/rai/Some Austrailian academics are also working on this under the acronym "BIOS".
No comments:
Post a Comment